HOME > LATEST
LATEST
-
ORGANIZATION New JPMA Task Force to Respond to ICH-GL and PMD Act Amendments
April 22, 2025
-
ORGANIZATION JPMA to Investigate the Status of Application of Japanese PI Waiver
April 22, 2025
-
REGULATORY LDP Tariff Task Force Broadly OKs First Proposal
April 22, 2025
-
BUSINESS Pfizer to Donate RSV Jabs to 12 Municipalities in Noto Peninsula
April 22, 2025
-
BUSINESS Ono Links Arms with Jorna on RNA Editing Therapeutics
April 22, 2025
-
BUSINESS Novo Partners with Asahikawa City on Obesity Measures
April 22, 2025
-
BUSINESS Enhertu Hits Mark in 1st Line Breast Cancer with PIII Trial Win
April 22, 2025
-
BUSINESS Effexor Filed for Generalized Anxiety Disorder in Japan: Viatris
April 22, 2025
-
REGULATORY GSK’s Blenrep, Moderna RSV Jab Edge Closer to Japan Approval with Panel OK
April 22, 2025
-
ACADEMIA Diabetes Society Flags DKA Risk for AstraZeneca’s Truqap after Report of Death
April 21, 2025
-
BUSINESS Celltrion, Nippon Kayaku to Unify Remicade/Herceptin Biosimilars
April 21, 2025
-
BUSINESS CSL’s New HAE Drug Andembry Now Available in Japan
April 21, 2025
-
REGULATORY Ruling Coalition Wary of Scrapping Coverage for OTC-Like Drugs
April 21, 2025
-
REGULATORY Diuretic, Hypertension Drugs, Zolgensma under PMDA Risk Review
April 21, 2025
-
BUSINESS Nippon Shinyaku’s EGPA Drug Gets Orphan Tag in US
April 21, 2025
-
REGULATORY Chugai’s DMD Gene Therapy Now in Line for Conditional Approval
April 21, 2025
-
REGULATORY Lower House Passes Bill to Amend PMD Act
April 21, 2025
-
REGULATORY MOF Tells LDP Members Govt Can Address Inflation with Current Budget Policy
April 21, 2025
-
BUSINESS Meiji/KM Biologics Change Target Strain of Investigational COVID Jab
April 21, 2025
-
BUSINESS Eye Drop for Myopia Control Enters PII Study in Japan: Rohto
April 21, 2025
ページ
I recently attended a fantastic conference hosted by Prospection Japan, and one speaker, Dr. Joe Ledsam, really blew me away with his insights. He shared some truly fascinating developments about how AI is set to revolutionize healthcare, from how doctors…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…